Effect of antiemetic drugs on decrease in gastric emptying in experimental model of motion sickness in rats

Acta Pharmacologica Sinica

Volumn 24, Issue 4, 2003, Pages 296-300

  Gupta, Y K ^a   Chaudhary, Geeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cisapride; Gastric emptying; Mepyramine; Motion sickness; Propranolol; Rats; Scopolamine

Indexed keywords

ANTIEMETIC AGENT; CISAPRIDE; GRANISETRON; MEPYRAMINE; PROPRANOLOL; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EXPERIMENTAL MODEL; MALE; MOTION SICKNESS; NONHUMAN; RAT; ROTATION; STOMACH EMPTYING; STOMACH MOTILITY; TIME SERIES ANALYSIS;

ANIMALS; ANTIEMETICS; CISAPRIDE; GASTRIC EMPTYING; MALE; MOTION SICKNESS; PROPRANOLOL; RATS; RATS, WISTAR; ROTATION; SCOPOLAMINE;

EID: 0037383873     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Money K. Motion sickness. Physiol Rev 1970; 50: 1-39.
2. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47: 395-406.
3. Takeda N, Morita M, Hasegawa S, Horii A, Kubo T, Matsunaga T. Neuropharmacology of motion sickness and emesis. A review. Acta Otolaryngol 1993; 501 Suppl: 10-5.
4. Hu S, Grant WF, Stern RM, Koch KL. Motion sickness severity and physiological correlates during repeated exposures to a rotating optokinetic drum. Aviat Space Environ Med 1991; 62: 308-14.
5. Scarpignato C, Capovilla T, Bertaccini G. Action of cerulin on gastric emptying of conscious rats. Arch Int Pharmacodyn Ther 1980; 246: 286-94
6. Takeda N, Morita M, Horii A, Nishiike S, Kitahara T, Uno A. Neural mechanisms of motion sickness. J Med Invest 2001; 48: 44-59.
7. Sharma SS, Gupta SK, Kochupillai V, Seth SD, Gupta YK. Cisplatin-induced pica behavior in rats is prevented by antioxidants with anfiemetic activity. Environ Toxicol Pharmacol 1997; 3: 145-9.
8. Takeda N, Hasegawa S, Morita M, Matsunaga T. Pica in rats is analogous to emesis: an animal model in emesis research. Pharmacol Biochem Behav. 1993; 45: 817-21
9. Thornton WE, Linder BJ, Moore TP, Pool SL. Gastrointestinal motility in space motion sickness. Aviat Space Environ Med 1987; 58: A16-2.
10. Sharma SS, Gupta YK. Effects of antioxidants on cisplatin-induced delay in gastric emptying in rats. Environ Toxicol Pharmacol 1997; 3: 41-6.
11. Hasler WL, Kim MS, Chey WD, Stevenson V, Stein B, Owyang C. Central cholinergic and alpha-adrenergic mediation of gastric slow wave dysrhythmias evoked during motion sickness. Am J Physiol 1995; 268 (4 Pt 1): G539-47.
12. Koch KL. Illusory self-motion and motion sickness: a model for brain-gut interactions and nausea. Dig Dis Sci 1999; 44 (8 Suppl): 53S-57S.
13. Kohl RL. Endocrine correlates of susceptibility to motion sickness. Aviat Space Environ Med 1985; 56: 1158-65.
14. Muth ER, Thayer JF, Stern RM, Friedman BH, Drake C. The effect of autonomic nervous system activity on gastric myoelectrical activity: does the spectral reserve hypothesis hold for the stomach? Biol Psychol 1998; 47: 265-78.
15. Monnikes H, Tebbe JJ, Hildebrandt M, Arck P, Osmanoglou E, Ros J, et al. Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis Sci 2000; 19: 201-11.